{
    "clinical_study": {
        "@rank": "161625", 
        "arm_group": [
            {
                "arm_group_label": "dexmeditomidine group D", 
                "arm_group_type": "Experimental", 
                "description": "1 \u03bcg/kg dexmedetomidine infusion for sedation"
            }, 
            {
                "arm_group_label": "Midazolam group M", 
                "arm_group_type": "Experimental", 
                "description": "2-3mg midazolam for sedation"
            }, 
            {
                "arm_group_label": "group control", 
                "arm_group_type": "No Intervention", 
                "description": "patients accept spinal anesthesia with saline sedation"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators designed a study to determine whether dexmedetomidine versus midazolam\n      combined with spinal anesthesia would provide same postoperative sleep quality in patients\n      undergoing transurethral prostatic resection."
        }, 
        "brief_title": "Postoperative Sleep Quality of Patients Sedation With i.v. Dexmedetomidine or Midazolam Undergoing TURP", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Quality of Patients Undergoing TURP", 
        "detailed_description": {
            "textblock": "The investigators designed a study to determine whether dexmedetomidine versus midazolam\n      combined with spinal anesthesia would provide same postoperative sleep quality in patients\n      undergoing transurethral prostatic resection.The bispectral index score (BIS) was monitored\n      during the operation.The sleep quality will be test with Pittsburgh sleep quality index\n      (PSQI)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants were deemed eligible if they were candidates for spinal anesthesia\n             undergoing TURP\n\n        Exclusion Criteria:\n\n          -  Existing cognitive impairment as evidenced by Mini-Mental State Examination scores\n             below 24 (of the 30 possible points)\n\n          -  A history of neurological and psychiatric diseases including stroke, and psychosis\n\n          -  Severe visual or hearing impairment\n\n          -  Unwillingness to comply with the protocol or procedures"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02142595", 
            "org_study_id": "20140515"
        }, 
        "intervention": [
            {
                "arm_group_label": "dexmeditomidine group D", 
                "description": "dexmedetomidine 1 \u03bcg/kg", 
                "intervention_name": "dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "dexmedetomidine"
            }, 
            {
                "arm_group_label": "Midazolam group M", 
                "description": "Midazolam 2-3 mg", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "dexmedetomidine", 
            "midazolam", 
            "sleep quality", 
            "delirium"
        ], 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "email": "mahong5466@yahoo.com", 
                "last_name": "Hong Ma, M.D.,PhD", 
                "phone": "86-024-83283100"
            }, 
            "facility": {
                "address": {
                    "city": "Shenyang", 
                    "country": "China", 
                    "state": "Liaoning", 
                    "zip": "110001"
                }, 
                "name": "the First Hospital of China Medical University"
            }, 
            "investigator": {
                "last_name": "Wenfei Tan, M.D.,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparison of the Postoperative Sleep Quality of Patients Sedation With i.v. Dexmedetomidine or Midazolam Undergoing Transurethral Prostatic Resection(TURP)", 
        "other_outcome": {
            "description": "Postoperative delirium was tested with CAM-ICU 3 days after surgery", 
            "measure": "Postoperative delirium", 
            "safety_issue": "Yes", 
            "time_frame": "3 days after surgery"
        }, 
        "overall_contact": {
            "email": "winfieldtan@hotmail.com", 
            "last_name": "Wenfei Tan, M.D.,PhD.", 
            "phone": "024-83283100"
        }, 
        "overall_official": {
            "affiliation": "Department of Anesthesiology the first hospital of CMU", 
            "last_name": "Hong Ma, M.D.,PhD.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "All patients underwent baseline Pittsburgh sleep quality index (PSQI) were assessed one day before operation, postoperative first and second night. The primary outcome measure is change of PSQI.", 
            "measure": "The Change of postoperative sleep quality", 
            "safety_issue": "Yes", 
            "time_frame": "preoperation, first and second postoperative night"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02142595"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China Medical University, China", 
            "investigator_full_name": "Wen-fei Tan", 
            "investigator_title": "the Anesthesiology Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "CSF samples were obtained using lumbar puncture in the L2-L3 or L3-L4 intervertebral space. After a successful puncture, 3 mL of CSF was obtained and collected in polypropylene tubes and brought to the laboratory immediately. The blood samples were collected before induction of anesthesia and 3 days after the end of surgery.", 
            "measure": "The change of interleukin-6 level in cerebrospinal fluid (CSF) and plasma samples", 
            "safety_issue": "Yes", 
            "time_frame": "preoperation and the third postoperative day"
        }, 
        "source": "China Medical University, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "China Medical University, China", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}